Source link : https://www.newshealth.biz/health-news/does-semaglutide-increase-risk-for-optic-neuropathy/
TOPLINE: The use of semaglutide, a glucagon-like peptide 1 receptor agonist (GLP-1 RA), is not associated with an increased risk for nonarteritic anterior ischemic optic neuropathy (NAION) in patients with type 2 diabetes, obesity, or both conditions. METHODOLOGY: Researchers conducted a retrospective cohort study using data from the TriNetX Analytics Network to investigate the potential […]
Author : News Health
Publish date : 2024-11-08 11:19:20
Copyright for syndicated content belongs to the linked Source.
